Dr Ryan Haumschild Discusses Payer, Provider Perspectives on Prior Authorization in Rare Diseases
September 19th 2023Ryan Haumschild, PharmD, MS, MBA, director of pharmacy at Emory Winship Cancer Institute, shares his unique perspectives as both a provider and payer on the use of prior authorizations (PAs) and "Gold Cards" in patients with rare diseases.
Watch
What We’re Reading: Health Programs Threatened; Midwives Needed; Sleep Deprivation and Screen Time
September 19th 2023Various health programs may shut down at the end of September without congressional action; maternal health experts push for midwife workforce expansion amidst high maternal mortality rates in the United States; studies find that heightened screen time in teens and tweens before bed can result in a lack of sleep.
Read More
Relative Benefit in Survival, Reduction in TE/MAVE Risk With Eculizumab for Patients With PNH
September 19th 2023When patients with paroxysmal nocturnal hemoglobinuria (PNH) received eculizumab, survival rates increased and thromboembolic events/major adverse vascular events (TE/MAVE) decreased.
Read More
NCCN Working Group Presents Health-Related Social Needs Recommendations at Policy Summit
September 19th 2023During this session at the National Comprehensive Cancer Network (NCCN) Policy Summit, Yelak Biru, MSc, and Crystal S. Denlinger, MD, explained the importance of screening for and addressing health-related social needs.
Read More
Dr Kristine Slam: Value-Based Care in Breast Cancer Requires Collaboration
September 19th 2023In this interview from our Institute for Value-Based Medicine® event, held in partnership with the Zangmeister Cancer Center of Columbus, Ohio, on September 14, Kristine Slam, MD, FACP, Central Ohio Surgical Associates, discusses the benefits of value-based care in the breast cancer space.
Watch
Prevalence, Incidence of Early-Onset CRC Increased in Individuals Aged 40 to 49 Years
September 18th 2023Although mortality and disability-adjusted life-years remained stable, the prevalence and incidence of early-onset colorectal cancer (CRC) increased globally in individuals aged 40 to 49 years.
Read More
Dr Tariq Cheema Discusses Patient, Family Experiences With Virtual ICU Care
September 18th 2023Tariq Cheema, MD, division chair of pulmonary critical care sleep and allergy medicine at Allegheny Health Network (AHN), discusses how the virtual ICU (vICU) program has benefited patients and their families during the COVID-19 pandemic in terms of both patient care and managing resources.
Watch
Differences in Ophthalmology Residents’ Medical Knowledge Ratings Could Indicate Gender Disparities
September 18th 2023Although major gender bias on the national level was not found, differences in medical knowledge (MK) ratings could be an indicator of gender bias in ophthalmology education.
Read More
What We’re Reading: Mental Health AI Tools; Obesity Drug Shortages; Health Worker Mask Guidelines
September 18th 2023Artificial intelligence (AI) tools offer potential solutions to the growing demand in mental health; patients face weight loss drug shortages and insurance complications; updated mask guidelines cause worry among health care workers.
Read More
OneOncology and Its Practice Partners Celebrate 5 Years of Cancer Care Excellence
September 18th 2023“OneOncology was started by physicians and for physicians,” said Jeff Patton, MD, OneOncology CEO. “As we’ve grown and enhanced world-class cancer care in communities across the country, strengthening practice independence and empowering their decision-making has always been our north star."
Read More
Dr Susan Spratt Discusses Diabetes Management Services at Duke Health
September 17th 2023Susan Spratt, MD, senior medical director, Duke Population Health Management Office, breaks down the the prevalence of diabetes in the United States and discusses current diabetes initiatives at Duke Health.
Watch
Diet and Exercise Intervention Associated With Better pCR in TNBC or HR+, HER2– BC
September 16th 2023Despite seeming to elicit more pathological complete responses (pCRs) in patients with hormone receptor–positive (HR+), HER2-negative triple-negative breast cancer (BC) receiving neoadjuvant chemotherapy, diet and exercise did not affect relative dose intensity.
Read More
Switching Back to Originator From Biosimilar Infliximab Results in Higher Discontinue Rates
September 16th 2023One-fourth of patients who switched to an infliximab biosimilar retransitioned back to the originator, but they were more likely to subsequently discontinue treatment due to an unwanted response after switching back.
Read More
Novel PET-Based Radiomics Signature Predicts CAR T Efficacy in DLBCL
September 15th 2023A PET-based radiomics signature was able to predict the efficacy of chimeric antigen receptor (CAR) T-cell therapy and performed better than conventional PET biomarkers in patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL).
Read More
Study: Financial Incentives Increase PrEP Initiation, Adherence for HIV
September 15th 2023Applying novel and effective approaches based on behavioral economics for pre-exposure prophylaxis (PrEP) dissemination programs could help to tailor the programs to the populations and settings of areas with high HIV burden.
Read More